Homology Medicines, Inc.

Symbole: 0T6G.L

LSE

21.56

USD

Prix du marché aujourd'hui

  • -0.7390

    Ratio P/E

  • -0.0083

    Ratio PEG

  • 283.62M

    Cap MRK

  • 0.00%

    Rendement DIV

Homology Medicines, Inc. Structure de gestion

Informations sur la direction

Nom de l'entrepriseTitre de l'entreprise
Dr. Paul Alloway J.D., Ph.D.President & Chief Operating Officer
Mr. Charles Michaud Jr., CPAVice President of Finance, Corporate Controller & Treasurer
Ms. Theresa McNeelyChief Communications Officer & Patient Advocate
Dr. Saswati Chatterjee Ph.D.Co-Founder & Member of Scientific Advisory Board